Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Prenetics Global Ltd. (PRENW:NASDAQ), powered by AI.
Prenetics Global Ltd. is currently trading at $0.02. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Prenetics Global Ltd. on Alpha Lenz.
View Prenetics Global Ltd.'s valuation metrics on Alpha Lenz.
“Prenetics Global Ltd.'s ROE is -24.6%. Explore profitability and growth together.”
Ask for details →Prenetics Global Ltd. is a biotechnology company known for its dynamic role in the field of genetic testing and health diagnostics. Its primary function is to provide advanced solutions for personalized healthcare, specializing in genomics testing, which includes genetic predisposition tests and diagnostic services for various health conditions. The company’s cutting-edge technology supports sectors such as healthcare, pharmaceuticals, and consumer wellness, offering individuals and healthcare professionals the information needed to make informed health decisions. Prenetics is significantly recognized for its contributions to preventive healthcare and its role in empowering consumers with access to their genetic information. By doing so, it plays a pivotal part in the broader movement towards personalized medicine, helping to tailor healthcare experiences to individual genetic profiles. Based in Hong Kong, Prenetics is strategically positioned to serve the expanding Asian market and beyond, aligning with global trends emphasizing the integration of technology in healthcare. The company’s operations underscore an important shift in the healthcare paradigm, focusing on proactive approaches rather than reactive treatment, making it a key player in the future of biotech innovation.
“Prenetics Global Ltd.'s ROE is -24.6%. Explore profitability and growth together.”
Ask for details →Prenetics Global Ltd. (ticker: PRENW) is a company listed on NASDAQ in the Healthcare sector (Diagnostics & Research). It has approximately 285 employees.
The current price is $0.018 with a P/E ratio of -x and P/B of -x.
ROE is -24.58% and operating margin is -166.19%. Annual revenue is $31M.